Skip to main content

Y13 (Entecavir 0.5 mg)

Pill with imprint Y13 is White, Round and has been identified as Entecavir 0.5 mg. It is supplied by Yaopharma Co., Ltd..

Entecavir is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Entecavir 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Y13

Entecavir

Imprint
Y13
Strength
0.5 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (nrtis)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Yaopharma Co., Ltd.
Manufacturer
Chongqing Carelife Pharmaceutical Co., Ltd.
National Drug Code (NDC)
50771-0013

Get help with Imprint Code FAQs.

Related Images for "Y13"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.